Sanofi (SNYNF) News Today $108.37 +0.37 (+0.34%) As of 01/31/2025 12:18 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestSustainability All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Sanofi’s Strong Growth Prospects and Strategic Initiatives Justify Buy RatingJanuary 31 at 2:07 PM | markets.businessinsider.comPositive Report for Sanofi (SNYNF) from DZ BANK AGJanuary 31 at 2:07 PM | markets.businessinsider.comPress Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025January 30 at 2:41 PM | finance.yahoo.comBernstein Remains a Buy on Sanofi (SNYNF)January 30 at 2:41 PM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sumitomo Dainippon Pharma Co (OtherDNPUF) and Sanofi (OtherSNYNF)January 30 at 9:41 AM | markets.businessinsider.comSanofi (SNYNF) Expected to Announce Earnings on ThursdayJanuary 28, 2025 | americanbankingnews.comVigil Neuroscience gains after early-stage data for Alzheimer’s drug (update)January 24, 2025 | seekingalpha.comUBS Sticks to Its Buy Rating for Sanofi (SNYNF)January 23, 2025 | markets.businessinsider.comJ.P. Morgan Remains a Hold on Sanofi (SNYNF)January 16, 2025 | markets.businessinsider.comSanofi (SNYNF) Gets a Buy from JefferiesDecember 18, 2024 | markets.businessinsider.comPositive Phase 3 Trial Results for Rilzabrutinib Support Buy Rating Amidst Strong Efficacy and Safety ProfileDecember 10, 2024 | markets.businessinsider.comDZ BANK AG Sticks to Its Hold Rating for Sanofi (SNYNF)October 28, 2024 | markets.businessinsider.comSanofi (SNYNF) Receives a Sell from Deutsche BankOctober 28, 2024 | markets.businessinsider.comSanofi Q3 Profit Rises - Quick FactsOctober 25, 2024 | markets.businessinsider.comSanofi’s Strategic Moves and Financial Prospects Drive Buy RatingOctober 24, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Irhythm Technologies (IRTC)October 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Sanofi (SNY)October 21, 2024 | markets.businessinsider.comSanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella To CD&ROctober 21, 2024 | markets.businessinsider.comBerenberg Bank Remains a Buy on Sanofi (SNYNF)October 18, 2024 | markets.businessinsider.comSanofi’s Strong Market Position and Growth Potential Justifies Buy RatingOctober 18, 2024 | markets.businessinsider.comDeutsche Bank Sticks to Their Sell Rating for Sanofi (SNYNF)October 16, 2024 | markets.businessinsider.comKymera's Protein Degradation Technology: A Promising Bet For Long-Term Biotech InvestorsOctober 6, 2024 | seekingalpha.comSanofi’s Market Advantage and Growth Trajectory: A Strong Buy RecommendationSeptember 26, 2024 | markets.businessinsider.comSanofi: A Strong Buy on Earnings Growth, Pipeline Progress, and Market CatalystsSeptember 20, 2024 | markets.businessinsider.comFulcrum Therapeutics: Tough Day As Losmapimod FSHD Phase 3 Misses BadlySeptember 12, 2024 | seekingalpha.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN) and Sanofi (OtherSNYNF)September 12, 2024 | markets.businessinsider.comSanofi, RadioMedix, Orano Med Sign Deal For Next-Gen Radioligand Medicine For Rare CancersSeptember 12, 2024 | markets.businessinsider.comNurix Therapeutics: Promising Science, Major Collaborations, Undifferentiated DataSeptember 4, 2024 | seekingalpha.comBuy Rating Affirmed for Sanofi Amid Promising Tolebrutinib Trials and Significant Market OpportunitySeptember 2, 2024 | markets.businessinsider.comSanofi (SNYNF) Receives a Buy from JefferiesSeptember 2, 2024 | markets.businessinsider.comSanofi: Tolebrutinib For NrSPMS Meets Primary Goal In HERCULES Trial; Fails In GEMINI Trial For RMSSeptember 2, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Gilead Sciences (GILD)July 25, 2024 | markets.businessinsider.comBuy Rating for Sanofi: Undervalued Stock with Strong Growth and Strategic InitiativesJuly 19, 2024 | markets.businessinsider.comKepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)July 19, 2024 | markets.businessinsider.comSanofi, Formation Bio, OpenAI Announce AI CollaborationMay 21, 2024 | markets.businessinsider.comBuy Rating for Sanofi: Strong Growth and Attractive Valuation Amidst Pipeline Optionality and Strategic LeadershipMay 14, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)May 13, 2024 | markets.businessinsider.comSanofi Strikes COVID-19 Vaccine Agreement With Novavax; To Take Minority StakeMay 10, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), NewAmsterdam Pharma Company (NAMS) and Humana (HUM)April 29, 2024 | markets.businessinsider.comSanofi Q1 Profit Drops, Sales Rise; Confirms FY24 OutlookApril 25, 2024 | markets.businessinsider.comSanofi Pharma Ltd.April 23, 2024 | wsj.comSanofi succeeds in late-stage trial for blood disorder candidateApril 23, 2024 | msn.comMaintaining Buy Rating on Sanofi: A Resilient Financial Outlook Despite Currency HeadwindsApril 18, 2024 | markets.businessinsider.comNo link between weight loss drugs and suicidal thoughts, EU regulator concludesApril 12, 2024 | msn.comU.S. CDC warns bacteria causing meningitis are on the riseMarch 30, 2024 | msn.comSanofi: My Top Pick In Big PharmaMarch 25, 2024 | seekingalpha.com6 reasons to buy Teva Pharmaceuticals stock sooner than later (SNYNF)Investors seeking a long-term and undervalued pharmaceutical play should take a close look at Teva Pharmaceuticals, and here are six reasons whyFebruary 26, 2024 | marketbeat.comSanofi (SNYNF) Price Target Increased by 6.32% to 117.27February 24, 2024 | msn.comBuy Rating Affirmed for Sanofi on Strong Sales and Promising Financial OutlookFebruary 5, 2024 | markets.businessinsider.comPress Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology PipelineFebruary 2, 2024 | finance.yahoo.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYNF and its competitors with MarketBeat's FREE daily newsletter. Email Address SNYNF Media Mentions By Week SNYNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNYNF News Sentiment▼0.590.69▲Average Medical News Sentiment SNYNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNYNF Articles This Week▼70▲SNYNF Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FFNTF News Today AGNPF News Today ALST News Today HIPH News Today LEAS News Today ARNI News Today AZNCF News Today AVXT News Today AVVH News Today AXIM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SNYNF) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump loves DeepSeekPresident Trump could be ecstatic. And it's all thanks to DeepSeek. The secretive Chinese startup just r...Weiss Ratings | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
